Baxion
Screening
Tags
Alerts
Theme
Silexion Therapeutics Corporation
SLXN
·
NASDAQ
·
$0.43
Share Price as of 11/2
·
$240,822
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/14/26
10-K/A
FY 2025
05/19/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
03/17/26
10-Q
Q3 ended 09/30/25
11/12/25
Disclosures
Filter
8-K
Current report
10/26/26
8-K
Current report
09/30/26
8-K
Current report
09/29/26
8-K
Current report
09/28/26
8-K
Current report
09/25/26
Prospectuses and Registrations
Filter
S-3
Shelf registration
10/28/26
424B3
Prospectus
09/29/26
424B4
Prospectus
08/13/26
S-1/A
Registration statement (amended)
08/10/26
S-1
Registration statement (IPO)
08/07/26
Proxies
Filter
DEFA14A
Additional proxy materials
10/19/26
DEF 14A
Definitive proxy
10/05/26
PRE 14A
Preliminary proxy
09/25/26
DEFA14A
Additional proxy materials
09/16/26
DEFA14A
Additional proxy materials
09/09/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/28/26
SC 13D/A
Beneficial ownership (amended)
08/19/26
SC 13G
Beneficial ownership
08/18/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13D/A
Beneficial ownership (amended)
06/23/26
Other
Filter
EFFECT
Request for effectiveness
08/11/26
EFFECT
Request for effectiveness
06/18/26
CORRESP
Correspondence with the SEC
06/16/26
UPLOAD
Letter from the SEC
06/15/26
EFFECT
Request for effectiveness
05/11/26
Latest Filings
Filter
S-3
Shelf registration
10/28/26
8-K
Current report
10/26/26
DEFA14A
Additional proxy materials
10/19/26
DEF 14A
Definitive proxy
10/05/26
8-K
Current report
09/30/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
09/28/26
SC 13D/A
Beneficial ownership (amended)
08/19/26
SC 13G
Beneficial ownership
08/18/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13D/A
Beneficial ownership (amended)
06/23/26